Hepatitis C

"Hepatitis C" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

INFLAMMATION of the LIVER in humans caused by HEPATITIS C VIRUS, a single-stranded RNA virus. Its incubation period is 30-90 days. Hepatitis C is transmitted primarily by contaminated blood parenterally, and is often associated with transfusion and intravenous drug abuse. However, in a significant number of cases, the source of hepatitis C infection is unknown.

Descriptor ID	D006526
MeSH Number(s)	C02.440.440 C02.782.350.350 C06.552.380.705.440
Concept/Terms	Hepatitis C Hepatitis C Parenterally-Transmitted Non-A, Non-B Hepatitis Parenterally Transmitted Non A, Non B Hepatitis PT-NANBH Hepatitis, Viral, Non-A, Non-B, Parenterally-Transmitted

Below are MeSH descriptors whose meaning is more general than "Hepatitis C".

Diseases [C]
Virus Diseases [C02]
Hepatitis, Viral, Human [C02.440]
Hepatitis C [C02.440.440]
RNA Virus Infections [C02.782]
Flaviviridae Infections [C02.782.350]
Hepatitis C [C02.782.350.350]
Digestive System Diseases [C06]
Liver Diseases [C06.552]
Hepatitis [C06.552.380]
Hepatitis, Viral, Human [C06.552.380.705]
Hepatitis C [C06.552.380.705.440]

Below are MeSH descriptors whose meaning is related to "Hepatitis C".

Below are MeSH descriptors whose meaning is more specific than "Hepatitis C".

Hepatitis C
Hepatitis C, Chronic

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Hepatitis C" by people in this website by year, and whether "Hepatitis C" was a major or minor topic of these publications.

Bar chart showing 64 publications over 22 distinct years, with a maximum of 5 publications in 2005 and 2006 and 2015 and 2016

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
1997	2	0	2
1998	0	1	1
1999	1	0	1
2001	3	0	3
2002	1	0	1
2003	2	1	3
2004	4	0	4
2005	3	2	5
2006	3	2	5
2007	2	0	2
2008	1	1	2
2009	1	3	4
2010	4	0	4
2011	1	1	2
2012	3	0	3
2013	3	0	3
2014	3	1	4
2015	5	0	5
2016	4	1	5
2017	3	0	3
2018	1	0	1
2019	1	0	1

Below are the most recent publications written about "Hepatitis C" by people in Profiles.

Li T, Su S, Zhao Y, Deng R, Fan M, Wang R, Sharma M, Zeng H. Barriers to the Prevention and Control of Hepatitis B and Hepatitis C in the Community of Southwestern China: A Qualitative Research. Int J Environ Res Public Health. 2019 01 15; 16(2).

View in: PubMed
Di Poto C, He S, Varghese RS, Zhao Y, Ferrarini A, Su S, Karabala A, Redi M, Mamo H, Rangnekar AS, Fishbein TM, Kroemer AH, Tadesse MG, Roy R, Sherif ZA, Kumar D, Ressom HW. Identification of race-associated metabolite biomarkers for hepatocellular carcinoma in patients with liver cirrhosis and hepatitis C virus infection. PLoS One. 2018; 13(3):e0192748.

View in: PubMed
Salek TP, Katz AR, Lenze SM, Lusk HM, Li D, Des Jarlais DC. Seroprevalence of HCV and HIV infection among clients of the nation's longest-standing statewide syringe exchange program: A cross-sectional study of Community Health Outreach Work to Prevent AIDS (CHOW). Int J Drug Policy. 2017 10; 48:34-43.

View in: PubMed
Chandler R, Gordon MS, Kruszka B, Strand LN, Altice FL, Beckwith CG, Biggs ML, Cunningham W, Chris Delaney JA, Flynn PM, Golin CE, Knight K, Kral AH, Kuo I, Lorvick J, Nance RM, Ouellet LJ, Rich JD, Sacks S, Seal D, Spaulding A, Springer SA, Taxman F, Wohl D, Young JD, Young R, Crane HM. Cohort profile: seek, test, treat and retain United States criminal justice cohort. Subst Abuse Treat Prev Policy. 2017 05 16; 12(1):24.

View in: PubMed
Rashrash M, Maneno M, Wutoh A, Ettienne E, Daftary M. Predictors of hepatitis C testing intention among African American Baby Boomers. J Epidemiol Glob Health. 2017 06; 7(2):119-122.

View in: PubMed
Henry-Akintobi T, Laster N, Trotter J, Jacobs D, Johnson T, King Gordon T, Miller A. The Health, Enlightenment, Awareness, and Living (HEAL) Intervention: Outcome of an HIV and Hepatitis B and C Risk Reduction Intervention. Int J Environ Res Public Health. 2016 09 24; 13(10).

View in: PubMed
Klein MB, Althoff KN, Jing Y, Lau B, Kitahata M, Lo Re V, Kirk GD, Hull M, Kim HN, Sebastiani G, Moodie EE, Silverberg MJ, Sterling TR, Thorne JE, Cescon A, Napravnik S, Eron J, Gill MJ, Justice A, Peters MG, Goedert JJ, Mayor A, Thio CL, Cachay ER, Moore R. Risk of End-Stage Liver Disease in HIV-Viral Hepatitis Coinfected Persons in North America From the Early to Modern Antiretroviral Therapy Eras. Clin Infect Dis. 2016 11 01; 63(9):1160-1167.

View in: PubMed
Abadie R, Welch-Lazoritz M, Gelpi-Acosta C, Reyes JC, Dombrowski K. Understanding differences in HIV/HCV prevalence according to differentiated risk behaviors in a sample of PWID in rural Puerto Rico. Harm Reduct J. 2016 Mar 08; 13:10.

View in: PubMed
Setiawan VW, Wei PC, Hernandez BY, Lu SC, Monroe KR, Le Marchand L, Yuan JM. Disparity in liver cancer incidence and chronic liver disease mortality by nativity in Hispanics: The Multiethnic Cohort. Cancer. 2016 05 01; 122(9):1444-52.

View in: PubMed
Eyre NS, Hampton-Smith RJ, Aloia AL, Eddes JS, Simpson KJ, Hoffmann P, Beard MR. Phosphorylation of NS5A Serine-235 is essential to hepatitis C virus RNA replication and normal replication compartment formation. Virology. 2016 Apr; 491:27-44.

View in: PubMed

People

Explore

Similar Concepts

Top Journals